Trade Summary

1 week ago, Khan Najat, serving as Chief R, D Commercial Officer at Recursion Pharmaceuticals, Inc. (RXRX), sold 124,403 shares at $4.41 per share, for a total transaction value of $548,592.00. Following this transaction, Khan Najat now holds 611,135 shares of RXRX.

This sale represents a 17.00% decrease in Khan Najat's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, December 22, 2025 and publicly disclosed via SEC Form 4 filing on Monday, December 29, 2025, 7 days after the trade was made.

Recursion Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.